BiotechTube

DS-5670a + Placebo

Phase 1/2Completed
0 watching 0 views this week⚡ Active
41
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Covid19

Conditions

Covid19

Trial Timeline

Mar 15, 2021 → Jul 14, 2022

NCT ID
NCT04821674

About DS-5670a + Placebo

DS-5670a + Placebo is a phase 1/2 stage product being developed by Daiichi Sankyo for Covid19. The current trial status is completed. This product is registered under clinical trial identifier NCT04821674. Target conditions include Covid19.

Hype Score Breakdown

Clinical
13
Activity
8
Company
10
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT04821674Phase 1/2Completed

Competing Products

20 competing products in Covid19

See all competitors
ProductCompanyStageHype Score
Favipiravir + NitazoxanideStrides PharmaPhase 2
51
Icosapent ethylAmarin CorporationApproved
77
GX-03 + Petrolatum ointmentTurn TherapeuticsPhase 2
44
Cytotoxic T LymphocytesTevogen BioPhase 1
25
Pegylated Interferon-α2bZydus LifesciencesPhase 2
52
BaricitinibEli LillyPhase 3
77
LY3819253 + Placebo + Remdesivir + VIR-7831 + BRII-196/BRII-198 + AZD7442 + MP0420 + PF-07304814Eli LillyPhase 3
77
bamlanivimabEli LillyApproved
85
1x10^9 vp AZD1222 + 5x10^9 vp AZD1222 + 1x10^10 vp AZD1222AstraZenecaPhase 1
33
Sacubitril / Valsartan Oral Tablet [Entresto] + PlaceboNovartisPhase 1/2
41
PirfenidoneRochePre-clinical
23
Remdesivir + Remdesivir Placebo + CorticosteroidGilead SciencesPhase 3
76
RemdesivirGilead SciencesPre-clinical
22
Remdesivir + Remdesivir Placebo + Aviptadil + Aviptadil Placebo + CorticosteroidGilead SciencesPhase 3
76
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer)PfizerPhase 3
76
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine + CoronaVac COVID-19 vaccine + ChAdOx1 nCoV-19 Covid-19 Vaccine + Ad26.COV2.S COVID-19 VaccinePfizerPre-clinical
22
Tofacitinib 10 mg + PlaceboPfizerPhase 3
76
BNT162b2PfizerPhase 2
51
Anakinra + 0.9% SalineSwedish Orphan BiovitrumPhase 2
51
COVID-19 vaccine Pfizer (3 doses) + COVID-19 vaccine Pfizer (2 doses) + COVID-19 mRNA Vaccine Moderna (3 doses) + COVID-19 mRNA Vaccine Moderna (2 doses) + COVID-19 mRNA Vaccine Moderna (1 dose)SanofiApproved
84

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85